BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 12874240)

  • 1. Injury primes the innate immune system for enhanced Toll-like receptor reactivity.
    Paterson HM; Murphy TJ; Purcell EJ; Shelley O; Kriynovich SJ; Lien E; Mannick JA; Lederer JA
    J Immunol; 2003 Aug; 171(3):1473-83. PubMed ID: 12874240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+CD25+ regulatory T cells control innate immune reactivity after injury.
    Murphy TJ; Ni Choileain N; Zang Y; Mannick JA; Lederer JA
    J Immunol; 2005 Mar; 174(5):2957-63. PubMed ID: 15728508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced TLR4 reactivity following injury is mediated by increased p38 activation.
    Maung AA; Fujimi S; Miller ML; MacConmara MP; Mannick JA; Lederer JA
    J Leukoc Biol; 2005 Aug; 78(2):565-73. PubMed ID: 15857937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant.
    Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S
    Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages.
    Matsuguchi T; Musikacharoen T; Ogawa T; Yoshikai Y
    J Immunol; 2000 Nov; 165(10):5767-72. PubMed ID: 11067935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut.
    Ortega-Cava CF; Ishihara S; Rumi MA; Kawashima K; Ishimura N; Kazumori H; Udagawa J; Kadowaki Y; Kinoshita Y
    J Immunol; 2003 Apr; 170(8):3977-85. PubMed ID: 12682225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immune responses to Rhodococcus equi.
    Darrah PA; Monaco MC; Jain S; Hondalus MK; Golenbock DT; Mosser DM
    J Immunol; 2004 Aug; 173(3):1914-24. PubMed ID: 15265925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking the "two-hit" response following injury to enhanced TLR4 reactivity.
    Murphy TJ; Paterson HM; Kriynovich S; Zang Y; Kurt-Jones EA; Mannick JA; Lederer JA
    J Leukoc Biol; 2005 Jan; 77(1):16-23. PubMed ID: 15496450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways.
    Sato S; Nomura F; Kawai T; Takeuchi O; Mühlradt PF; Takeda K; Akira S
    J Immunol; 2000 Dec; 165(12):7096-101. PubMed ID: 11120839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.
    Darville T; O'Neill JM; Andrews CW; Nagarajan UM; Stahl L; Ojcius DM
    J Immunol; 2003 Dec; 171(11):6187-97. PubMed ID: 14634135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
    Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
    J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication.
    Equils O; Schito ML; Karahashi H; Madak Z; Yarali A; Michelsen KS; Sher A; Arditi M
    J Immunol; 2003 May; 170(10):5159-64. PubMed ID: 12734363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury.
    Cairns BA; Barnes CM; Mlot S; Meyer AA; Maile R
    J Trauma; 2008 Apr; 64(4):1069-77; discussion 1077-8. PubMed ID: 18404077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors 2 and 4, and acute phase cytokine gene expression in dexamethasone and growth hormone treated dairy calves.
    Eicher SD; McMunn KA; Hammon HM; Donkin SS
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):115-25. PubMed ID: 15010221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent.
    Huang LY; Aliberti J; Leifer CA; Segal DM; Sher A; Golenbock DT; Golding B
    J Immunol; 2003 Aug; 171(3):1441-6. PubMed ID: 12874236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
    Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
    J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis.
    Koedel U; Angele B; Rupprecht T; Wagner H; Roggenkamp A; Pfister HW; Kirschning CJ
    J Immunol; 2003 Jan; 170(1):438-44. PubMed ID: 12496429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells.
    Frleta D; Noelle RJ; Wade WF
    J Leukoc Biol; 2003 Dec; 74(6):1064-73. PubMed ID: 12960264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.
    Dziarski R; Wang Q; Miyake K; Kirschning CJ; Gupta D
    J Immunol; 2001 Feb; 166(3):1938-44. PubMed ID: 11160242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.